Related Experiment Video
Updated: Jun 30, 2025

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
Published on: April 8, 2013
Angiotensin II Receptor Blockers Are Associated With Reduced Valvular Fibrosis in Women With Aortic Stenosis
Rasmus Carter-Storch1, Emma Le Nezet2, Mulham Ali3
1Institut Universitaire de Cardiologie et de Pneumologie, Université Laval, Québec, Québec, Canada; Department of Cardiology, Odense University Hospital, Odense, Denmark.
Angiotensin receptor blockers (ARBs) show a greater antifibrotic effect in women with aortic stenosis (AS). This study found ARBs significantly reduced valvular fibrosis in women, suggesting a sex-specific therapeutic role in managing AS progression.
Area of Science:
- Cardiology
- Pharmacology
- Fibrosis Research
Background:
- Angiotensin receptor blockers (ARBs) possess antifibrotic properties that may impede aortic stenosis (AS) progression.
- Women exhibit greater valvular fibrosis in AS compared to men, suggesting a potentially enhanced effect of ARBs in females.
- This study aimed to investigate the differential impact of ARBs on aortic valve remodeling in men and women.
Purpose of the Study:
- To assess the impact of Angiotensin receptor blockers (ARBs) on aortic valve remodeling.
- To determine if the antifibrotic effects of ARBs are sex-specific in patients with aortic stenosis (AS).
Main Methods:
- Analysis of 1321 patients undergoing aortic valve replacement between 2006 and 2013.
- Exclusion of patients with incomplete echocardiographic or histologic data.
- Classification of valves into four phenotypes based on Warren-Yong and fibrosis scores: mild calcification/fibrosis, severe calcification/fibrosis, predominant fibrosis, and predominant calcification.
Main Results:
- Patients in the predominant fibrosis group were more frequently female and had bicuspid valves, with less frequent ARB use compared to the predominant calcification group.
- Female sex was independently associated with the predominant fibrosis phenotype, with a significant interaction observed between female sex and ARB use.
- Women taking ARBs demonstrated significantly lower valvular fibrosis scores compared to women not taking ARBs; this effect was not observed in men.
Conclusions:
- In patients with moderate-to-severe aortic stenosis (AS), a negative association exists between Angiotensin receptor blockers (ARBs) use and valvular fibrosis in women.
- The antifibrotic effects of ARBs appear to be sex-specific, indicating a potentially larger therapeutic role for ARBs in women with AS.
- Further research into sex-specific mechanisms and treatments for AS is warranted.
More Related Videos
14:14Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Antihypertensive Drugs: Direct Renin Inhibitors
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Heart Failure Drugs: Diuretics